Abstract:Abstract Background Macromoleculization of nitroxides has been an effective strategy to improve low relaxivities and poor in vivo stability, however, nitroxides-based metal-free magnetic resonance imaging (MRI) macromolecular contrast agents (mCAs) are still under-performed. These mCAs do not possess a high nitroxides content sufficient for a cumulative effect. Amphiphilic nanostructures in these mCAs are not stable enough for highly efficient protection of nitroxides and do not have adequate molecular flexibility for full contact of the paramagnetic center with the peripheral water molecules. In addition, these mCAs still raise the concerns over biocompatibility and biodegradability due to the presence of macromolecules in these mCAs. Results Herein, a water-soluble biodegradable nitroxides-based mCA (Linear pDHPMA-mPEG-Ppa-PROXYL) was prepared via covalent conjugation of a nitroxides (2,2,5,5-tetramethyl-1-pyrrolidinyl- N -oxyl, PROXYL) onto an enzyme-sensitive linear di-block poly[ N -(1, 3-dihydroxypropyl) methacrylamide] (pDHPMA). A high content of PROXYL up to 0.111 mmol/g in Linear pDHPMA-mPEG-Ppa-PROXYL was achieved and a stable nano-sized self-assembled aggregate in an aqueous environment (ca. 23 nm) was formed. Its longitudinal relaxivity ( r 1 = 0.93 mM − 1 s − 1 ) was the highest compared to reported nitroxides-based mCAs. The blood retention time of PROXYL from the prepared mCA in vivo was up to ca. 8 h and great accumulation of the mCA was realized in the tumor site due to its passive targeting ability to tumors. Thus, Linear pDHPMA-mPEG-Ppa-PROXYL could provide a clearly detectable MRI enhancement at the tumor site of mice via the T1WI SE sequence conventionally used in clinical Gd 3+ -based contrast agents, although it cannot be compared with DTPA-Gd in the longitudinal relaxivity and the continuous enhancement time at the tumor site of mice. Additionally, it was demonstrated to have great biosafety, hemocompatibility and biocompatibility. Conclusions Therefore, Linear pDHPMA-mPEG-Ppa-PROXYL could be a potential candidate as a substitute of metal-based MRI CAs for clinical application. Graphic Abstract

Aggregation-induced T1/T2 contrast enhancement for magnetic resonance imaging-guided intraoperative surgery

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

An Albumin-Binding T-1-T-2 Dual-Modal MRI Contrast Agents for Improved Sensitivity and Accuracy in Tumor Imaging

Novel lanthanide–polymer complexes for dye-free dual modal probes for MRI and fluorescence imaging

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

Time-Dependent T-1-T-2 Switchable Magnetic Resonance Imaging Realized by C(rgdyk) Modified Ultrasmall Fe3O4 Nanoprobes

A Hexanuclear Gadolinium(III)-Based Nanoprobe for Magnetic Resonance Imaging of Tumor Apoptosis

A dual-targeted Gd-based contrast agent for magnetic resonance imaging in tumor diagnosis

Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent.

Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging

Synergistic Enhancement of Fluorescence and Magnetic Resonance Signals Assisted by Albumin Aggregate for Dual-Modal Imaging

Targeted Biodegradable Dendritic MRI Contrast Agent for Enhanced Tumor Imaging

In Vivo Tumor Visualization Through MRI Off‐On Switching of NaGdF4–CaCO3 Nanoconjugates

Improving Sensitivity of Magnetic Resonance Imaging by Using a Dual-Targeted Magnetic Iron Oxide Nanoprobe.

Dual-Modality Imaging Probes with High Magnetic Relaxivity and Near-Infrared Fluorescence Based Highly Aminated Mesoporous Silica Nanoparticles

Synergetic Enhancement of Fluorescence and Magnetic Resonance Signals Assisted by Albumin Cage

A nitroxides-based macromolecular MRI contrast agent with an extraordinary longitudinal relaxivity for tumor imaging via clinical T1WI SE sequence

A rapid-response smart nanoplatform with dual T1-T2 activation for acidic microenvironment imaging

Nagdf4 Nanoparticle-Based Molecular Probes for Magnetic Resonance Imaging of Intraperitoneal Tumor Xenografts in Vivo

Redox-triggered Aggregation of ESIONPs with Switchable T1 to T2 Contrast Effect for T2-weighted Magnetic Resonance Imaging.